Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q4 2018 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$47.54K$47.54Kderived−97.2% vs Q4 2017 Net Income-$486.92K-$486.92KderivedN/M vs Q4 2017 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$24,920−98.3% Operating Incomederived-$467,553N/M Operating Cash Flowderived$85,353−68.6% Free Cash Flowderived$85,353−75.9% Margins · derivedGross margin52.4%−33.6 pt vs Q4 2017
Operating margin-983.6%−981.9 pt vs Q4 2017
Net margin-1024.3%−1038.9 pt vs Q4 2017
ended Dec 31, 2018 · filed Apr 1, 2019 · 91 d after period end